Program
9.00 Registration
9.20 Institutional Welcome
SESSION I
10.00 – 10.20 1.1 – Di Timodeo G (PhD in Genetics and Molecular Biology)
“CircRNA epitrascriptome: the importance of being methylated”
10.20 – 10.40 1.2 – Trani G (PhD in Cellular and Developmental Biology)
“Clinical-genetic features and peculiar muscle histopathology in infantile
DNM1L-related mitochondrial epileptic encephalopathy”"
10.40 – 11.00 1.3 –Cerutti G (PhD in Biochemistry)
“Identification of substrate specificity in a fungal glucose dehydrogenase: a sugar sweet structural approach.”
11.00 – 11.20 1.4 – Orlando A (PhD in Immunological, Hematological and Rheumatological Sciences)
“Notch- dependent induction of myeloid derived suppressor cells in T-cell acute lymphoblastic leukemia.”
11.20 – 11.50 Coffee break and POSTER SESSION I
SESSION II
11.50 – 12.10 2.1 – Liguori F (PhD in Life Science)
“Drosophila melanogaster as a model to study in vivo the functional role of
Transposable Elements in Huntington’s disease pathogenesis.”
12.10 – 13.00 Invited speaker: Vittorio Venturi
International centre for genetic engeneering and biotechnology, Trieste
“Pathobiomes and interspecies signalling in plant associated bacteria”
13.00 - 14.30 Lunch and POSTER SESSION II
SESSION III
14.30 – 15.20 Invited speaker: Daniele Castagnolo
King’s College, London
" Hybridization and photochemical approaches in the development of antibacterial agents to tackle antimicrobial resistance"
15.20 – 15.40 3.1 – Marabitti V (PhD in Human Biology and Medical Genetics)
“ATM pathway activation limits R- loop-associated genomic instability in Werner syndrome cells.”
15.40 – 16.00 3.2 – Cartocci G (PhD in Infectious diseases, Microbiology and Public Health: )
“Structural and functional MRI study in mentally ill persons considered socially dangerous with
diminished penal responsibility.”
16.00 – 16.20 Coffee break and POSTER SESSION III
SESSION IV
16.20 – 16.40 4.1 – Vescarelli E (PhD in Experimental Medicine)
“Targeting NRP1 through mir200c as a novel therapeutic strategy in olaparib resistant ovarian cancer.”
16.40 – 17.00 4.2 – Angrisani A (PhD in Molecular Medicine:)
“The oncosuppressor KCASH2^KCTD21 negatively modulates the mitotic checkpoint protein
MAD2, dalaying the mitotic exit.”
17.00 – 17.20 4.3 – Tucciarione L (PhD in Morphogenesis and Tissue Engineering:)
“Epigenetic and transcriptomic profiling of fibro adipongeic progenitors during DMD progression of HDACi treatment.”
17.20 – 17.40 4.4 – Maccelli A (PhD in Pharmaceutical Sciences)
“Curcumin-Cu(II) complexation: a combined MS/MS and IRMPD study.”
17.40 Concluding remarks